Aligos Therapeutics, Inc. (ALGS)
2.15
-0.42
(-16.34%)
USD |
NASDAQ |
Nov 11, 16:00
2.09
-0.06
(-2.79%)
After-Hours: 19:32
Aligos Therapeutics Price : 2.15 for Nov. 11, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 3.99 | 3.99 | 2.56 | 2.57 | 194611.0 |
| Nov 09, 2026 | 4.25 | 4.65 | 3.95 | 3.95 | 141298.0 |
| Nov 06, 2026 | 4.44 | 4.855 | 4.00 | 4.07 | 101672.0 |
| Nov 05, 2026 | 5.004 | 5.004 | 4.505 | 4.51 | 40213.00 |
| Nov 04, 2026 | 4.89 | 5.14 | 4.721 | 5.02 | 27845.00 |
| Nov 03, 2026 | 4.65 | 4.950 | 4.65 | 4.75 | 13999.00 |
| Nov 02, 2026 | 4.81 | 4.99 | 4.60 | 4.60 | 23044.00 |
| Oct 30, 2026 | 4.99 | 5.05 | 4.750 | 4.80 | 23846.00 |
| Oct 29, 2026 | 5.02 | 5.375 | 5.02 | 5.03 | 47201.00 |
| Oct 28, 2026 | 4.66 | 5.26 | 4.66 | 5.17 | 23453.00 |
| Oct 27, 2026 | 4.67 | 4.81 | 4.63 | 4.74 | 9528.00 |
| Oct 26, 2026 | 4.98 | 4.98 | 4.55 | 4.65 | 33001.00 |
| Oct 23, 2026 | 4.76 | 4.92 | 4.65 | 4.78 | 4849.00 |
| Oct 22, 2026 | 5.005 | 5.005 | 4.78 | 4.82 | 15253.00 |
| Oct 21, 2026 | 4.88 | 5.235 | 4.88 | 4.96 | 13127.00 |
| Oct 20, 2026 | 4.74 | 5.241 | 4.74 | 5.03 | 42814.00 |
| Oct 19, 2026 | 4.95 | 5.08 | 4.61 | 4.84 | 82018.00 |
| Oct 16, 2026 | 5.32 | 5.50 | 4.86 | 4.86 | 67553.00 |
| Oct 15, 2026 | 5.40 | 5.409 | 5.186 | 5.39 | 25467.00 |
| Oct 14, 2026 | 5.50 | 5.600 | 5.21 | 5.23 | 60558.00 |
| Oct 13, 2026 | 5.465 | 5.60 | 5.20 | 5.51 | 33974.00 |
| Oct 12, 2026 | 5.50 | 5.64 | 5.30 | 5.53 | 57270.00 |
| Oct 09, 2026 | 5.27 | 5.442 | 5.27 | 5.34 | 9059.00 |
| Oct 08, 2026 | 5.25 | 5.53 | 5.08 | 5.31 | 37365.00 |
| Oct 07, 2026 | 5.33 | 5.525 | 5.230 | 5.32 | 19405.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.21 |
| Amgen, Inc. | 468.10 |
| Anika Therapeutics, Inc. | 13.91 |
| BioCryst Pharmaceuticals, Inc. | 7.655 |
| Imunon, Inc. | 0.70 |
Price Related Metrics
| PS Ratio | 0.6658 |
| Price to Book Value | 1.188 |
| Earnings Yield | -296.0% |
| Market Cap | 13.43M |